Physician profile
Margaret Ann Riso
NPI 1417337320
$19,132.05
in general payments reported to CMS, 2019-2025
21 companies · $3,725 in 2025
The $3,725 reported for 2025 was more than what 91% of Pain Medicine (Anesthesiology) providers received nationally (typical 2025 total: $458).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $766 · 2022: $1,590 · 2023: $958 · 2024: $12K · 2025: $3,725.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $8,423 · Travel and Lodging: $8,340 · Education: $13.38.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $8,422.72 |
| Travel and Lodging | $8,339.92 |
| Education | $13.38 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $6,659.07 | 2021-2025 | Proclaim, Eterna |
| Medtronic, INC. | $4,258.32 | 2021-2025 | Intellis Adaptivestim, Synchromedii, Inceptiv |
| Saluda Medical Americas, INC. | $2,592.90 | 2024-2025 | Evoke |
| Boston Scientific Corporation | $1,670.47 | 2024-2025 | Wavewriter Alpha Prime 16, General - Pain Management, Intracept |
| Nevro Corp. | $1,417.90 | 2021-2024 | Senza |
| Biotronik Nro, INC. | $601.20 | 2024-2025 | Prospera |
| Spr Therapeutics, INC | $558.13 | 2021-2025 | Sprint Pns System |
| Curonix LLC | $279.93 | 2024 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Globus Medical, INC. | $250.18 | 2025 | Senza, Vyrsa V1 |
| Vertos Medical, INC. | $231.73 | 2024 | Mild Device Kit |
| Mml US, INC. | $218.53 | 2023-2024 | Reactiv8 |
| Nalu Medical, INC. | $115.32 | 2024-2025 | Nalu Neurostimulation System |
| Convatec INC. | $87.67 | 2024-2025 | |
| Averitas Pharma INC. | $55.16 | 2025 | Qutenza |
| Vertex Pharmaceuticals Incorporated | $24.01 | 2025 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Painteq LLC | $23.11 | 2024 | Painteq |
| Virtus Pharmaceuticals LLC | $22.49 | 2025 | Levorphanol Tartrate |
| Pacira Pharmaceuticals Incorporated | $17.84 | 2025 | Iovera, Zilretta |
| Spinal Simplicity, LLC | $17.26 | 2024 | Ha Minuteman G3-R |
| Scilex Pharmaceuticals INC. | $17.08 | 2024 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $13.75 | 2025 | Relistor |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Margaret Riso listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.